[Initial surgical management of squamous carcinoma of the vulva].

Vulvar cancer accounts for approximately 4% of gynecological malignancies. At the Instituto Nacional de Cancerologia in Mexico it occupies the fourth place. The purpose of this study is to assess the management of squamous carcinoma of the vulva with initial surgical treatment. It is a descriptive retrospective, observational study, from January 1, 2002 to December 31, 2012. Twenty-seven patients, clinical stages I, II, or III, initial surgical management, with at least one year of follow-up were included. In 51.85% a partial vulvectomy was performed and in 40.74% a wide excision; 66.66% underwent inguinofemoral dissection. Recurrence occurred in 25.91% of cases and the overall survival at 10 years was 63%. It is concluded that with invasion of up to 1 mm of lymph node, affection is 0%; with invasion of 1 mm and up to 5 mm this increases to 25%; an invasion of more than 5 mm implies up to 45%. Recurrence in our study was primarily distant, necessitating long-term monitoring with emphasis on symptoms to request imaging studies when suspected. Adjuvant therapy should be offered to patients with positive nodes, close or positive margins, and tumors larger than 4 cm.

[1]  N. Waugh,et al.  A Thirty-year Review of Vulvar Cancer in Jamaica, 1978 to 2007. , 2014, The West Indian medical journal.

[2]  A. van der Zee,et al.  Application of sentinel nodes in gynaecological cancer therapy , 2013, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].

[3]  L. Woelber,et al.  Management of patients with vulvar cancer: a perspective review according to tumour stage , 2013, Therapeutic advances in medical oncology.

[4]  J. Schilder,et al.  Invasive Cancer of the Vulva , 2012 .

[5]  S. Pecorelli Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium” , 2010 .

[6]  Jorge Felipe Montero León,et al.  Cáncer de la vulva: cuadro clínico, histopatología y supervivencia (1980 a 2004) , 2008 .

[7]  Achim Schneider,et al.  Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Kryscio,et al.  The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus. , 2007, Gynecologic oncology.

[9]  A. García-Jiménez,et al.  Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer. , 2007, Gynecologic Oncology.

[10]  R. Angioli,et al.  Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. , 2005, Gynecologic oncology.

[11]  A. Gadducci,et al.  Patterns of recurrence in patients with squamous cell carcinoma of the vulva , 2000, Cancer.

[12]  D. Gallup,et al.  Carcinoma of the Vulva in Young Women , 1995, Obstetrics and gynecology.

[13]  J. Bouma,et al.  The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. , 1995, Gynecologic oncology.

[14]  B. Karlan,et al.  Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. , 1994, Gynecologic oncology.

[15]  C. Berman,et al.  Lymphoscintigraphy in vulvar cancer: A pilot study , 1992, Gynecologic oncology.

[16]  Gerhard Jentzsch,et al.  Working group on , 1991 .

[17]  J. Heaps,et al.  Surgical‐pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva , 1991, Gynecologic oncology.